Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

  

Volume: 23S3 - May 1997

PREVENTING THE TRANSMISSION OF BLOODBORNE PATHOGENS IN HEALTH CARE AND PUBLIC SERVICE SETTINGS

IV. Bibliography

  1. LCDC. Recommendations for prevention of HIV transmission in health-care settings. CDWR 1987;13S3:1-10.

  2. LCDC. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings. CDWR 1988;14:117-24.

  3. LCDC. Universal precautions: Report of a consensus committee meeting. CDWR 1989;15:23-8.

  4. LCDC. Bloodborne pathogens in the health care setting: risk  for transmission. CCDR 1992;18:177-84.

  5. LCDC.  An integrated protocol to manage health care workers exposed to bloodborne pathogens.  CCDR 1997;23S2:1-14.

  6. Health and Welfare Canada. Infection control guidelines for isolation and precaution techniques. Ottawa: Health and Welfare Canada, 1992. (Supply and Services Canada, Cat. No. H30-11-6-1E.)

  7. Ricketts M, Deschamps L. Reported seroconversions to human immunodeficiency virus among workers worldwide - a review. Can J Infect Control 1992;7:85-90.

  8. Ricketts M, Deschamps L, Elmslie K et al. National surveillance of occupational exposure to the human immunodeficiency virus. Can J Infect Dis 1992;3:290-94.

  9. National Institute for Occupational Safety and Health and CDC.  Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers.  Atlanta: CDC, 1989. DHHS(NIOSH) Publication No. 89-107.)

  10. Health and Welfare Canada.  Infection control guidelines for isolation and precaution techniques.  Ottawa: Health and Welfare Canada, 1985.

  11. CDC. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(suppl 2S):S1-18.

  12. Lynch P, Jackson MM, Cummings MJ et al. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987;107:243-46.

  13. Jackson MM, Lynch P. An attempt to make an issue less murky: a comparison of four systems for infection precautions. Infect Control Hosp Epidemiol 1991;12:448-50.

  14. Birnbaum D, Schulzer M, Mathias RG et al. Adoption of guidelines for universal precautions and body substance isolation in Canadian acute-care hospitals. Infect Control Hosp Epidemiol 1990;11:465-72.

  15. Gruendemann BJ. Are universal precautions (UPs) up for question?  Asepsis 1994;16:1.

  16. CDC. Isolation techniques for use in hospitals. 1st ed. Atlanta: CDC, 1970. (HEW Publication No. (CDC) 78-8314.)

  17. CDC. Acquired immunodeficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR 1982;31:577-80.

  18. CDC. Acquired immunodeficiency syndrome (AIDS): precautions for health-care workers and allied professionals. MMWR 1983;32:450-51.

  19. CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34:681-86, 691-95.

  20. CDC. Recommendations for preventing possible transmission of human T-lymphotropic virus type III/ lymphadenopathy-associated virus during invasive procedures. MMWR 1986;35:221-23.

  21. LCDC. Human immunodeficiency virus antibody testing in Canada. CDWR 1989;15:37-43.

  22. LCDC. Guidelines for prevention of HIV infection in organ and tissue transplantation. CDWR 1989;15S4:S1-17.

  23. LCDC. Guidelines for counselling persons who have had an occupational exposure to human immunodeficiency virus. CDWR 1990;16S2:S1-12.

  24. CDC. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989;38(suppl S6):S1-37.

  25. LCDC.  A national consensus on guidelines for establishment of a post-exposure notification protocol for emergency responders. CCDR 1995;21:169-80.

  26. CDC. Agent summary statement for human immunodeficiency viruses (HIVs) including HTLV-III, LAV, HIV-1, and HIV-2. MMWR 1988;37(suppl S4):S1-22.

  27. LCDC. Laboratory biosafety guidelines. 2nd ed. Ottawa: Health Canada, 1996. (Supply and Services Canada, Cat. No. MR21-1/1996-E.)

  28. American Academy of Pediatrics. Health guidelines for the attendance in day-care and foster care settings of children infected with HIV.  Pediatrics 1987;79:466-71.

  29. CDC. Education and foster care of children infected with HTLV-III/LAV. MMWR 1985;34:517-21.

  30. LCDC.  Guidelines for those responsible for day care and education of children with HTLV-III/LAV infection.  CDWR 1986;12:67-70.

  31. American Academy of Pediatrics.  Guidelines for human immunodeficiency virus (HIV)-infected children and their foster families.  Pediatrics 1992;89:681-83.

  32. Simmons B, Trusler M, Roccaforte J et al. Infection control for home health. Infect Control Hosp Epidemiol 1990;11:362-70.

  33. Marcus R, Srivastava PU, Bell DM et al. Occupational blood contact among prehospital providers.  Ann Emerg Med 1995;25:776-79.

  34. Roy E, Robillard P. Effectiveness of and compliance to preventative measures against occupational transmission of human immunodeficiency virus. Scand J Work Environ Health 1994;20:393-400.

  35. Gerberding JL. Does knowledge of human immunodeficiency virus infection decrease the frequency of occupational exposure to blood? Am J Med 1991;91(suppl 3B):S308-11.

  36. Cockcroft A, Elford J. Clinical practice and the perceived importance of identifying high risk patients. J Hosp Inf 1994;28:127-36.

  37. Birnbaum D. New national strategies for hospital infection control: a critical evaluation. Doctoral thesis. Vancouver: University of British Columbia, 1992.

  38. Stock SR, Gafni A, Bloch R. Universal precautions to prevent HIV transmission to health care workers: an economic analysis. Can Med Assoc J 1990;142:937-46.

  39. Doebbeling BN, Wenzel RP. The direct costs of universal precautions in a teaching hospital. JAMA 1990;264:2083-87.

  40. Gerberding JL. Management of occupational exposure to bloodborne viruses. N Engl J Med  1995;332:444-51.

  41. Jagger J, Powers RD, Day JS et al. Epidemiology and prevention of blood and body fluid exposures among emergency department staff.  J Emerg Med 1994;12;6:753-65.

  42. Hersey JC, Martin LS. Use of infection control guidelines by workers in healthcare facilities to prevent occupational transmission of HBV and HIV: results from a national survey. Infect Control Hosp Epidemiol 1994;15:243-52.

  43. McCormick RD, Meisch MG, Ircink FG et al. Epidemiology of hospital sharps injuries: a 14-year prospective study in the pre-AIDS and AIDS eras. Am J Med 1991;91(suppl 3B): S301-07.

  44. Birnbaum D, Schulzer M, Mathias RG et al. Needle stick injury: do preventive measures work? Dimens Health Serv 1990;67:29-32.

  45. Birnbaum D. Needle stick injuries among critical care nurses before and after adoption of Universal Precautions or Body Substance Isolation. J Healthc Mater Manage 1993;11:38-42.

  46. Hammond JS, Eckes JM, Gomez GA et al. HIV, trauma, and infection control: universal precautions are universally ignored. J Trauma 1990;30:555-58.

  47. Porteous MJL. Operating practices of and prevention taken by orthopaedic surgeons to avoid infection with HIV and hepatitis B virus during surgery. Br Med J 1990;301:167-69.

  48. Osterman JW. Beyond Universal Precautions. Can Med Assoc J 1995;152:1051-55.

  49. Wright JG, Young NL, Stephens D. Reported use of strategies by surgeons to prevent transmission of bloodborne diseases. Ibid:1089-95.

  50. Eustis TC, Wright SW, Wrenn KD et al. Compliance with recommendations for universal precautions among prehospital providers. Ann Emerg Med 1995;25:512-15.

  51. Henderson DK. Risks for exposures to and infection with HIV among health care providers in the emergency department. Emerg Med Clin North Am 1995;13:199-211.

  52. Kelen GD, Green GB, Hexter DA et al. Substantial improvement in compliance with universal precautions in an emergency department following institution of policy. Arch Intern Med 1991;151:2051-56.

  53. Jagger J, Hunt EH, Brand-Elnagger J et al. Rates of needle-stick injury caused by various devices in a university hospital. N Engl J Med 1988;319:284-88.

  54. Jagger J, Pearson RD. Universal precautions: still missing the point on needle sticks. Infect Control Hosp Epidemiol 1991;12:211-13.

  55. Ribner BS. An effective educational program to reduce the frequency of needle recapping. Infect Control Hosp Epidemiol 1990;11:635-38.

  56. Gerberding JL, Lewis FR, Schecter WP. Are Universal Precautions realistic? Surg Clin North Am 1995;75:1091-1104.

  57. Beekmann SE, Vlahov D, Koziol D et al.  Temporal association between implementation of Universal Precautions and a sustained, progressive decrease in percutaneous exposures to blood.  Clin Infect Dis 1994;18:562-69.

  58. Haiduven DJ, Phillips ES, Clemons KV et al.  Percutaneous injury analysis: consistent categorization, effective reduction methods, and future strategies.  Infect Control Hosp Epidemiol 1995;16:582-89.

  59. Wong ES, Stotka JL, Chinchilli VM et al.  Are Universal Precautions effective in reducing the number of occupational exposures among health care workers? JAMA 1991;265:1123-128.

  60. Fahey BJ, Koziol DE, Banks SM et al.  Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training.  Am J Med  1991;90:145-53.

  61. DiCarli G, Puro V, Binkin NJ, et al. Risk of human immunodeficiency virus infection for emergency department workers. J Emerg Med 1994;12:737-44.

  62. Wormser GP, Rabkin CS, Joline C. Frequency of nosocomial transmission of HIV infection among health care workers. N Engl J Med 1988;319:307-08.

  63. McKinney WP, Young MJ. The cumulative probability of occupationally-acquired HIV infection: the risks of repeated exposures during a surgical career. Infect Control Hosp Epidemiol 1990;11:243-47.

  64. Metler R. CDC Tracks occupational exposure to HIV. ASM News 1993;59:160.

  65. CDC. Surveillance for occupationally acquired HIV infection, United States, 1981-1992. MMWR 1992;41:823-25.

  66. Capilouto EI, Weinstein MC, Hemenway D et al. What is the dentist's occupational risk of becoming infected with hepatitis B or the human immunodeficiency virus?  Am J Public Health 1992;82:587-89.

  67. Ricketts MN, Robillard P, Roy E. Management of occupational exposure to human immunodeficiency virus. Pract Allerg Immunol 1995;10;3:92-8.

  68. Eves L, Gemmill I. A case of HIV infection possibly transmitted in an occupational setting - Ontario.  CCDR 1992;18:102-03.

  69. Robert LM, Chamberland ME, Cleveland JL. Investigations of patients of health care workers infected with HIV. Ann Intern Med 1995;122:653-57.

  70. CDC. Update: Investigations of patients who have been treated by HIV-infected health-care workers. MMWR 1992;41:344-46.

  71. Weber DJ, Hoffmann KK, Rutala WA. Management of the healthcare worker infected with human immunodeficiency virus: lessons from nosocomial transmission of hepatitis B virus. Infect Control Hosp Epidemiol 1991;12:625-30.

  72. Bell DM. Human immunodeficiency virus transmission in health care settings: risk and risk reduction. Am J Med 1991;91(suppl 3B): S294-300.

  73. Lewis DL, Arens M, Appleton SS et al. Cross-contamination potential with dental equipment. Lancet 1992;340:1252-54.

  74. Ciesielski C, Marianos D, Chin-Yih Ou et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med 1992;116:798-805.

  75. Owens DK, Nease RF Jr. Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk. Am J Med 1992;92:503-12.

  76. Goodman RA, Solomon SL. Transmission of infectious diseases in outpatient health care settings. JAMA 1991;265:2377-81.

  77. Hlady WG, Hopkins RS et al. Patient-to-patient transmission of hepatitis B in a dermatology practice. Am J Public Health 1993;83:1689-93.

  78. Shapiro CN, McCaig LF et al. Hepatitis B virus transmission between children in day care. Pediatr Infect Dis J 1989;8:870-75.

  79. Alter MJ, Ahtone J, Maynard JE. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983;99:330-33.

  80. Polish LB, Shapiro CN, Bauer F et al. Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med 1992;326:721-25.

  81. Johnston BL, MacDonald S, Lee S et al.  Nosocomial hepatitis B associated with orthopaedic surgery - Nova Scotia.  CCDR 1992;18:89-90.

  82. Garner JS. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:54-80.

  83. Robillard P. Epidemiology of bloodborne pathogens (HIV, HBV and HCV). Proceedings of a National Symposium on Risk and Prevention of Infectious Diseases for Emergency Response Personnel; 1994, Sept 27-28; Ottawa.  Ottawa: LCDC, 1995.

  84. Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of hemodialysis-associated hepatitis in the United States. J Infect Dis 1986;153:1149-51.

  85. CDC.  HIV transmission in a hemodialysis center - Columbia, 1991-1993. MMWR 1995;44:404-12.

  86. Hayashi J, Kishihara Y, Yamaji K et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995;90:794-99.

  87. Shakhgil'dian IV, Khukhlovich PA, Savin EA et al. Risk of infection with hepatitis B and C viruses of medical workers, patients in the haemodialysis ward, and vaccine prophylaxis of hepatitis B infection in these populations. Vopr Virusol 1994;39:226-29.

  88. Sampietro M, Badalamenti S, Salvadori S et al. High prevalence of a rare hepatitis C virus in patients treated in the same haemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995;47:911-17.

  89. Cendoroglo Neto M, Manzano SIR, Canziani ME et al. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit. Artif Organs 1995;19:251-55.

  90. Cendoroglo Neto M, Draibe SA, Silva AEB et al. Incidence of and risk factors for hepatitis B virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995;10:240-46.

  91. Blumberg A, Zehnder C, Burckhardt JJ. Prevention of hepatitis C infection in hemodialysis units. A prospective study. Ibid:230-33.

  92. LCDC.  Recommendations for providing hemodialysis treatment to patients infected with human immunodeficiency virus. CDWR 1987;13:111-12.

  93. Favero MS. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. Infect Control 1985;6:301-05.

  94. Petrosillo N, Puro V, Jagger J et al. The risks of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the hemodialysis setting. Am J Infect Control 1995;23:278-85.

  95. Shields JW. Patient-to-patient transmission of HIV. Lancet 1994;343:415.

  96. Tokars JI, Marcus R, Culver DG et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913-19.

  97. Ingerslev J, Mortensen E, Rasmussen K et al. Silent hepatitis- B immunization in laboratory technicians.  Scand J Clin Lab Invest 1988;48:333-36.

  98. Lanphear BP. Trends and patterns in the transmission of bloodborne pathogens to health care workers. Epidemiol Rev 1994;16:437-50.

  99. Lanphear BP, Linnemann CC, Cannon CG et al. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994;15:745-50.

  100. Alter MJ. Occupational exposure to hepatitis C virus: a dilemma. Infect Control Hosp Epidemiol 1994;15:742-44.

  101. CDC. Update: Human immunodeficiency virus infections in health care workers exposed to blood of infected patients. MMWR 1987;36:285-89.

  102. Petersen NJ, Bond WW, Favero MS. Air sampling for hepatitis B surface antigen in a dental operatory. J Am Dent Assoc 1979;99:465-67.

  103. CDC.  HIV/AIDS surveillance report. 1996;8 (1):15.

  104. Robillard P, Roy E.  Blood and body fluid exposures among health care workers in acute care hospitals.  In: Hagberg M, Hofmann F, Stöbel U, Westlander G. Occupational health for health care workers. International Commission on Occupational Health, 2nd International Congress, March 1994, Stockholm. 1st update. Landsberg:ecomed, 1995;3.6:158-65.

  105. Alberta Health, Office of the Provincial Nursing Consultant.  Needle stick injuries in Alberta. A survey of nurses and facilities/agencies. 1992.

  106. Roy E, Robillard P, Charlebois AM.  Blood and body fluid exposures among health care workers in non hospital settings.  In: Hagberg M, Hofmann F, Stöbel U, Westlander G.  Occupational health for health care workers. International Commission on Occupational Health, 2nd International Congress, March 1994, Stockholm. 1st update. Landsberg:ecomed, 1995;3.7:166-70.

  107. McGeer A, Simor AE, Low DE. Epidemiology of needle stick injuries in house officers. J Infect Dis 1990;162:961-64.

  108. Wright JG, McGeer A. Human immunodeficiency virus transmission between surgeons and patients in orthopaedic surgery. Clin Orthop 1993;297:272-81.

  109. White MC, Lynch P. Blood contact and exposures among operating room personnel: A multicenter study. Am J Infect  Control 1993;21:243-48.

  110. Tokars JI, Bell DM, Culver D et al. Percutaneous injuries during surgical procedures. JAMA 1992;267:2899-2904.

  111. Lowenfels AB, Wormser GP, Jain R. Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg 1989;124:1284-86.

  112. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 1995;23:273-77.

  113. Schechter MT, Marion SA, Elmslie KD et al. How many persons in Canada have been infected with human immunodeficiency virus? An exploration using backcalculation methods. Clin Invest Med 1992;15:331-45.

  114. Remis RS, Sutherland WD. The epidemiology of HIV and AIDS in Canada: current perspectives and future needs. Can J Public Health 1993;84(suppl 1):S34-8.

  115. LCDC. AIDS in Canada: quarterly surveillance update, June 30, 1996.

  116. Strike C, Sutherland D. HIV studies among inmates in Canadian prisons: a review. CCDR 1994;20:47-9.

  117. Calzavara LM, Major C, Myers T et al. The prevalence of HIV-1 infection among inmates in Ontario, Canada. Can J Public Health 1995;86:335-39.

  118. Hankins C, Gendron S, Lai-Tung MT et al. HIV-1 among incarcerated men in Quebec. CDWR 1991;17:233-35.

  119. CDC.  Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR 1995;44:929-33.

  120. Gomez y Perez C, Magis RC, Ortiz MR et al.  Mexican research about healthcare workers and AIDS. Presented at the XI International Conference on AIDS, Vancouver, July 7-12,1996.

  121. Gerberding JL. Limiting the risks of health care workers.  In: Sande MA, Volberding PA, eds. The medical management of AIDS.  4th ed.  Philadelphia: WB Saunders, 1995:89-101.

  122. LCDC. Quarterly surveillance update: AIDS in Canada. January, 1995.

  123. British Columbia Centre for Excellence in HIV/AIDS.  Protocols help protect against getting HIV - but you have to use them. CCDR 1996;22:54.

  124. Berthier A, Chamaret S, Fauchet R et al. Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in France. Lancet 1986;II:598-601.

  125. Friedland GH, Saltzman BR, Rogers MF et al. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med 1986;315:257-59.

  126. Fischl MA, Dickson GM, Scott GB et al. Evaluation of heterosexual partners, children and household contacts of adults with AIDS. JAMA 1987;257:640-44.

  127. Chamberland ME, Peterson LR, Munn VP et al. Human immunodeficiency virus among health care workers who donate blood. Ann Intern Med 1994:121:269-73.

  128. Kelley PW, Miller RN, Pomerantz R et al. Human immunodeficiency virus seropositivity among members of the active duty US Army 1985-89. Am J Public Health 1990;80:405-10.

  129. Cowan DN, Brundage JF, Pomerantz RS et al. HIV infection among members of the US Army Reserve Components with medical and health occupations. JAMA 1991;265:2826-30.

  130. Wahn V, Kramer H, Voit T et al. Horizontal transmission of HIV infection between two siblings. Lancet 1986;11:694.

  131. CDC. Human immunodeficiency virus transmission in household settings - United States. MMWR 1994;43:347-56.

  132. Fitzgibbon JE, Gaur S, Frenkel LD et al. Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med  1993;329:1835-41.

  133. CDC. Apparent transmission of human T-lymphotropic virus type III/lymphadenopathy- associated virus from a child to a mother providing health care. MMWR 1986;35:76-9.

  134. Brownstein A, Lugustyniak L, Fricke W. HIV Infection in two brothers receiving intravenous therapy for hemophilia. MMWR 1992;41:228-31.

  135. Brownstein A, Fricke W. HIV Transmission between two adolescent brothers with hemophilia. MMWR 1993;42:948-51.

  136. Lewis DL, Boe RK.  Cross-infection risks associated with current procedures for using high-speed dental handpieces. J Clin Microbiol 1992;30:401-06.

  137. Gooch B, Marianos D, Ciesielski C et al. Lack of evidence for patient-to-patient transmission of HIV in a dental practice. J Am Dent Assoc 1993;124:38-44.

  138. CDC.  Patient exposures to HIV during nuclear medicine procedures. MMWR 1992;41:575-78.

  139. Palmer DL, Hjeile BL, Wiley CA et al. HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am J Med 1994;97:289-95.

  140. Druce JD, Locarnini SA, Birch CJ. Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials. Med J Aust 1995;162:513-15.

  141. Tait AR, Tuttle DB. Preventing perioperative transmission of infection: a survey of anesthesiology practice. Anesth Analg 1995;80:764-69.

  142. Melnyk PS, Shevchuk YM, Conly JM et al. Contamination study of multiple-dose vials.  Ann Pharmacother 1993;27:274-78.

  143. Trépanier CA, Lessard MR, Brochu JG et al. Risk of cross-infection related to the multiple use of disposable syringes. Can J Anaesth 1990;37:156-59.

  144. Chant K, Lowe D, Rubin G et al. Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet 1993;342:1548.

  145. Koenig RE, Gautier T, Levy JA. Unusual intrafamilial transmission of human immunodeficiency virus. Lancet 1986;11:627. Letter.

  146. National Advisory Committee on Immunization. Statement on hepatitis B vaccine. CCDR 1993;19:104-15.

  147. LCDC. Notifiable diseases annual summary. CCDR 1995;21S1.

  148. Anderson C.  Sentinel Health Unit Surveillance System.  Can J Infect Dis  1994;5:207-09.

  149. Holton D, Anderson C, Giglia L. Sentinel Hepatitis Surveillance Study. Canadian Society for Epidemiology and Biostatics Conference, August 1995, St. John's, Nfld. Abstract.

  150. National Advisory Committee on Immunization.  Canadian immunization guide. 4th ed.  Ottawa, Ont: Health Canada, 1993. (Supply and Services Canada, Cat. no. H49-8/1993E.)

  151. Osterholm MT, Garayalde SM. Clinical viral hepatitis B among Minnesota hospital personnel - results of a 10-year survey. JAMA 1985;254:3207-12.

  152. Lanphear BP, Linnemann CC, Cannon CG et al. Decline of clinical hepatitis B in workers at a general hospital: relation to increasing vaccine-induced immunity. Clin Infect Dis 1993;16:10-4.

  153. Marmion BP, Burrell CJ, Tonkin RW et al. Dialysis-associated hepatitis in Edinburgh, 1969-1978. Rev Infect Dis 1982;4:619-37.

  154. Christenson B. Acute infections with hepatitis B virus in medical personnel during a 15-year follow-up. Am J Epidemiol 1985;122:411-17.

  155. Alter MJ, Hadler SC, Margolis HS et al. The changing epidemiology of hepatitis B in the United States: need for an alternative vaccination strategy. JAMA 1990;263:1218-22.

  156. Schneiderman LJ, Kaplan RM. Fear of dying and HIV infection vs. Hepatitis B infection.  Am J Public Health 1992;82:584-86.

  157. CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee. MMWR 1991;40(RR13):1-25.

  158. CDC. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings. MMWR 1988;37:377-88.

  159. Deseda C, Shapiro C, Carroll K et al. Hepatitis B virus transmission between a child and staff member at a day-care center. Ped Infect Dis J. 1994;13:828-29.

  160. Bell DM, Shapiro CN, Ciesielski CA et al.  Preventing bloodstream pathogen transmission from health-care workers to patients. The CDC perspective.  Surg Clin North Am.  1995;75:1189-1203.

  161. Osterholm MT. Infection control for the day care facility. Asepsis 1987;9:2-6.

  162. Cancio-Bello TP, de Medina M, Shorey J et al. An institutional outbreak of hepatitis B related to a human biting carrier. J Infect Dis 1982;146:652-56.

  163. MacQuarrie MD, Forghani B, Wolochow DA. Hepatitis B transmitted by a human bite. JAMA 1974;237:723-24.

  164. Kent GP, Brondum J, Keenlyside RA, et al.  A large outbreak of acupuncture-associated hepatitis B. Am J Epidemiol 1988;127:591-98.

  165. Canter J, Mackey K, Good LS et al. An outbreak of hepatitis B associated with jet injections in a weight reduction clinic.  Arch Intern Med 1990;150:1923-27.

  166. Ko YC, Lan SJ, Chang PY. An increased risk of hepatitis B virus infection from tattooing in Taiwan. Kao Hsiung I Hsueh Ko Hsueh Tsa Chic (Taiwan) 1990;6:237-43.

  167. Birnie GG, Quigley EM, Clements GB et al. Endoscopic transmission of hepatitis B virus. Gut 1983;24:171-74.

  168. Kaczmarek RG, Moore RM, McCrohan J et al. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med 1992;92:257-61.

  169. LCDC. Laboratory reports of human viral and selected non-viral infections in Canada - 1993. CCDR 1994; 20:209-14.

  170. LCDC. Guidelines and recommendations on the prevention and control of hepatitis C. CCDR 1995;21S2:1.

  171. LCDC. Antibody to hepatitis C virus in risk groups in Canada. CDWR 1990;16:23-5.

  172. Van der Poel C, Cuypers T, Reesink HW.  Hepatitis C virus six years on. Lancet 1994;344:1475-79.

  173. Murphy DG, Willems B, Delage G et al. Hepatitis C virus genotypes in patients and blood donors - Quebec. CCDR 1995;21:129-32.

  174. Kaldor JM, Archer GT, Buring Ml et al. Risk factors for hepatitis C virus infection in blood donors: a case control study. Med J Aust 1992;157:227-30.

  175. Weinstein JS, Poterucha JJ, Zein N et al. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995;22(suppl1):S154-59.

  176. Ford PM, White C, Kaufmann H et al. Seroprevalence of hepatitis C in a Canadian federal penitentiary for women. CCDR  1995;21:132-34.

  177. Pearson M, Mistry PS, Ford PM. Voluntary screening for hepatitis C in a Canadian federal penitentiary for men. CCDR 1995;21:134-36.

  178. Préfontaine RG, Chaudhary RK, Mathias RG. Analysis of risk factors associated with hepatitis B and C infections in correctional institutions in British Columbia. Can J Infect Dis 1994;5:153-56.

  179. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A et al. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995;7:237-41.

  180. Weber B, Rabenau H, Berger A et al. Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt, Germany. Int J Med Microbiol Virol Parasitol Infect Dis 1995;282:102-12.

  181. Meisel H, Reip A, Lu M et al. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin.  Lancet 1995;345:1209-11.

  182. Roy K, Bagg J, Follett EA. Occupational infection with hepatitis C virus in the healthcare setting. Dent Update 1994;21:100-02.

  183. Shapiro CN.  Occupational risk of infection with hepatitis B and hepatitis C virus.  Surgi Clin North Am.  1995;75:1047-70.

  184. Cooper BW, Krusell A, Tilton RC et al. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992;13:82-5.

  185. Wormser GP, Forseter G, Joline C et al. Low risk of hepatitis C infection following parenteral exposure to blood of HIV-infected patients. Am J Infect Control 1991;19:110.

  186. Lettau L. The A, B, C, D, and E of viral hepatitis: spelling out the risks for healthcare workers. Infect Control Hosp Epidemiol 1992;13:77-81.

  187. Kiyosawa K, Sodeyama T, Tanaka E et al. Hepatitis C in hospital employees with needle stick injuries. Ann Intern Med 1991;115:367-69.

  188. Mitsui T, Iwano K, Masuko K et al. Hepatitis C virus infection in medical personnel after needle stick accident.  Hepatology 1992;16:1109-14.

  189. Transmission of hepatitis C virus (HCV) from a hemodialysis patient to a medical staff member. Scand J Infect Dis 1990;22:757-58.

  190. Heydon J. Hepatitis C from needle stick injury. N Z Med J 1995;108:21.

  191. Chen M, Yun ZB, Sallberg M et al. Detection of hepatitis C virus RNA in the cell fraction of saliva before and after oral surgery. J Med Virol 1995;45:223-26.

  192. Dusheiko GM, Smith M, Scheuer PJ.  Hepatitis C virus transmitted by human bite. Lancet 1990;336:503-04.

  193. Figueiredo JF.  Transmission of hepatitis C virus but not human immunodeficiency virus type 1 by a human bite. Clin Infect Dis 1994;19:546-47.

  194. ACIP. Protection against viral hepatitis recommendations of the Immunization Practices Advisory Committee. MMWR 1990;39(RR2):1-26.

  195. Durand J, Lefevre P, Kaplanski G et al. Patient-to-patient transmission of hepatitis C virus. Lancet 1995;345:1442-43.

  196. Calabrese G, Vagelli G, Gonella M. Patient-to-patient transmission of hepatitis C virus. Lancet 1995;345:1443.

  197. CDC. Recommendations for counselling persons infected with human T-lymphotrophic virus, types I and II. MMWR 1993;42(RR9):1-13.

  198. American Academy of Pediatrics and American College of Obstetricians and Gynecologists.  Infection Control.  In: Freeman RK, Poland RL, Hauth JC, Merenstein GB, eds.  Guidelines for perinatal care. 3rd ed.  Elk Grove Village, IL: American Academy of Pediatrics, 1992:141-75.

  199. Hibberd PL. Patients, needles and health care workers. J Intraven Nurs 1995;18:65-76.

  200. Balcarek KB, Bagley R, Cloud GA et al. Cytomegalovirus infection among employees of a children's hospital: No evidence for increased risk associated with patient care. JAMA 1990;263:840-44.

  201. Dworskey ME, Welch K, Cassady G et al. Occupation risk for primary cytomegalovirus infection among pediatric health care workers. N Engl J Med 1983;309:950.

  202. LCDC.  Canadian contingency plan for viral hemorrhagic fevers and other related diseases. CCDR 1997;23S1:1-13.

  203. LCDC. Infection control guidelines: hospital environmental control. Ottawa: Health and Welfare Canada, 1988. (Supply and Services Canada, Cat. No. H30-11-6-4E.) Under revision.

  204. Healing TD, Hoffman PN, Young SRJ. The infection hazards of human cadavers. Commun Dis Rep Rev 1995;5:R61-68.

  205. Parlow JL. Blood contamination of drug syringes used in anaesthesia. Can J Anaesth 1989;6:S61-2. Abstract.

  206. Zabel P, Robichaud N, Hiltz A. Personnel and product protection during manipulation of blood products. J Nucl Med Technol 1993;21:33-7.

  207. Canadian Paediatric Society. CPS establishes guidelines on the use of banked human milk.  Ottawa: CPS, 1995.

  208. Treasury Board of Canada. Handbook of occupational safety and health.  5th ed. Ottawa: Treasury Board of Canada, 1994. (Supply and Services Canada, Cat. No. BT45-3/1994E.)

  209. Jagger J, Hunt EH, Pearson RD. Sharp object injuries in the hospital: causes and strategies for prevention. Am J Infect Control 1990;18:227-31.

  210. Transport Canada. Transportation of dangerous goods act, 1992. Amendment, schedule no. 16, 24 March 1994.  Can Gazette 1994;128:1526-35. (Part II).

  211. CAN/CGSB  43.125-M90. Packaging of infectious substances and diagnostic specimens. Canadian General Standards Board, Ottawa.

  212. Manian FA, Meyer L, Jenne J. Puncture injuries due to needles removed from intravenous lines: should the source patient routinely be tested for bloodborne infections?  Infect Control Hosp Epidemiol 1993;14:325-30.

  213. ECRI. Needle stick prevention devices. Health Devices 1991;20:154-80.

  214. LCDC.  Infection control guidelines for preventing infections associated with indwelling intravascular access devices. CCDR 1997. In press.

  215. CDC. Recommended infection control practices for dentistry. MMWR 1993;42(RR8):1-12.

  216. Wood PR. Cross infection control in dentistry: a practical illustrated guide. St. Louis; Mosby Year Book, 1992.

  217. Gerberding JL, Littell C, Tarkington A et al. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N Engl J Med 1990;322:1788-93.

  218. Mast ST, Woolwine GD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needle stick injury. J Infect Dis 1993;168:1589-92.

  219. Kotilainen HR, Brinker JP, Avato JL et al.  Latex and vinyl examination gloves quality control procedures and implications for health care workers. Arch Intern Med 1989;149:2749-53.

  220. Kotilainen HR, Avato JL, Gantz NM.  Latex and vinyl nonsterile examination gloves: status report on laboratory evaluation of defects by physical and biological methods.  Appl Environ Microbiol 1990;56:1627-30.

  221. Douglas AA, Neufeld PD, Wong RKW.  An interlaboratory comparison of standard test methods for medical gloves. Performance of Protective Clothing. 4th vol. (ASTM STP 1133). Philadelphia: American Society for Testing Materials, 1992.

  222. Checchi L, Conti S, D'Achille C.  Evaluation of the permeability of latex gloves for use in dental practice. Quintessence Int 1991;22:949-59.

  223. Korniewicz DM, Laughon BE, Cyr WH et al. Leakage of virus through used vinyl and latex examination gloves. J Clin Microbiol 1990;28:787-88.

  224. Korniewicz DM, Laughon BE, Butz A et al.  Integrity of vinyl and latex procedure gloves.  Nurs Res 1989;38:144-46.

  225. Fiehn NE, Westergaard J. Physical and microbiological quality of five different examination and surgical gloves before and after use in dental practice. Zentralbl Hyg Umweltmed 1993;195:27-36.

  226. American Society for Testing Materials. Standard specification for rubber examination gloves. ASTM D3578-95.  Philadelphia:  American Society for Testing Materials, 1995.

  227. Canadian General Standards Board. Sterile or non-sterile medical examination gloves for single use. CAN/CGSB-20.27-M91. Ottawa: Canadian General Standards Board, 1991.

  228. Hamann CP, Kick SA, Sullivan K. Taking up the gauntlet: accepting the challenge of glove evaluation. J Healthc Mater Manage 1993;11:24-37.

  229. Health Canada. Labelling of medical gloves to show primary materials of composition. Health Protection Branch Information Letter. June 16, 1995. (I.L.No. 814.)

  230. Stringer B, Smith JA, Scharf S et al. A study of the use of gloves in a large teaching hospital. Am J Infect Control 1991;19:233-36.

  231. Sussman GL, Beezhold DH. Allergy to Latex Rubber.  Ann Intern Med 1995;122:43-6.

  232. Bell DM, Shapiro CN, Gooch BF. Preventing HIV transmission to patients during invasive procedures. J Public Health Dent 1993;53:170-73.

  233. Young MA, Meyers M, McCulloch LD. Latex allergy. A guideline for perioperative nurses. AORN J 1992;56:288-302.

  234. Jack M. Latex allergies: A new infection control issue. Can J Infect Control 1994;9:67-70.

  235. Doebbeling BN, Pfaller MA, Houston AK et al. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing. Ann Intern Med 1988;109:394-98.

  236. Olsen RJ, Lynch P, Coyle MB et al. Examination gloves as barriers to hand contamination in clinical practice. JAMA 1993;270:350-53.

  237. Lund S, Jackson J, Leggett J et al. Reality of glove use and handwashing in a community hospital. Am J Infect Control 1994;22:352-57.

  238. Bond WW, Favero MS, Petersen NJ. Inactivation of hepatitis B virus by intermediate-to-high level disinfectant chemicals. J Clin Microbiol 1983;18:535-58.

  239. Prince DL, Prince HN, Thrainhart O et al. Methodological approaches to disinfection of human hepatitis B virus. J Clin Microbiol 1993;31:3296-3304.

  240. Rutala WA. APIC guidelines for infection control practice: APIC guideline for selection and use of disinfectants. Am J Infect Control 1990;18:99-117.

  241. Lewis DL, Arens M. Resistance of microorganisms to disinfection in dental and medical devices. Nature Medicine 1995;1:956-58.

  242. Health Canada. Laundry/linen services for health-related facilities. Revised ed.  Ottawa: Health Canada, 1994. (Supply and Services Canada, 1994.)

  243. ATSDR. Public health implications of medical waste: a report to congress. USPHS 1990, document #PB91-100271.

  244. Rutala WA, Mayhall CG. SHEA position paper: medical waste. Infect Control Hosp Epidemiol 1992;13:38-48.

  245. Rutala WA, Webber DJ. Infectious waste - mismatch between science and policy. N Engl J Med 1991;325:578-82.

  246. Canadian Standards Association. Handling of waste materials within health care facilities. Etobicoke: Can Stds Assoc, 1988. (Cat. No. CAN/CSA-Z317.10-1988.)

  247. Epstein JB, Mathias RG, Bridger D. Survey of knowledge of infectious disease and infection control practices of dental specialists. J Can Dent Assoc 1995;61:35-7.

  248. Leclair JM, Freeman J, Sullivan BF et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med 1987;317:329-34.

  249. Tucker JA, Meservey M, Grossi L et al. Prevention of nosocomial infections by isolation procedures. N Engl J Med 1988;318:326-27. Letter.

  250. Gruber M, Beavers FE, Johnson B et al. The relationship between knowledge about acquired immunodeficiency syndrome and implementation of universal precautions by registered nurses. Clin Nurs Specialist 1989;3:182-85.

  251. Seto WH, Ching PTY, Fung JPM et al. The role of communication in the alteration of patient-care practices in hospital, a prospective study. J Hosp Infect 1989;14:29-37.

  252. Willy ME, Dhillon GL, Lowen NL et al. Adverse exposures and universal precautions among a group of highly exposed health professionals. Infect Control Hosp Epidemiol 1990;11:351-56.

  253. Kabukoba JJ, Young P. Midwifery and body fluid contamination. Br Med J 1992;305:226;713.

  254. Miller K, Minnick M, Fox B. Occupational exposures in family practice residency programs. Fam Med 1995;27:90-1.

  255. Karrel AI. HIV-infected physicians: how best to protect the public? Can Med Assoc J 1995;152:1059-62.

  256. Allander T, Gruber A, Naghavi M el al. Frequent patient-to-patient transmission of hepatitis C virus in a hematology ward. Lancet 1995;345:603-07.

  257. Hoffman RE, Henderson N, O'Keefe K et al. Occupational exposure to human immunodeficiency virus (HIV)-infected blood in Denver, Colorado, police officers. Am J Epidemiol 1994;139:910-17.

  258. Jones PD. HIV transmission by stabbing despite zidovudine prophylaxis. Lancet 1991;338:884. Letter.

  259. Marcus R, Culver DH, Bell DM et al. Risk of immunodeficiency virus infection among emergency department workers. Am J Med 1993;94:363-70.

  260. Kelen GD, Hansen KN, Green GB et al. Determinants of emergency department procedure- and condition-specific universal (barrier) precaution requirements for optimal provider protection. Ann Emerg Med 1995;25:743-50.

  261. Cooper JS, Zagumny MJ. Predicting risk-reducing occupational AIDS behaviors in a sample of emergency medical personnel.  Percept Mot Skills 1994;79:1566.

  262. Moss ST, Clark RF, Guss DA et al. The management of sharps in the emergency department: is it safe?  J Emerg Med 1994;12:745-52.

  263. Renschler MF. Avoiding needle-stick injuries in the emergency department. Am J Emerg Med 1992;10:267-68.

  264. Tandberg D, Stewart K, Doezema D. Under-reporting of contaminated needle stick injuries in emergency health care workers. Ann Emerg Med 1991;20:66-70.

  265. National Fire Protection Association Standard 1973. Gloves for structural fire fighting (NFPA 1973). National Fire Protection Association, 1993.

  266. Panlilio AL, Foy DR, Edwards JR et al. Blood contacts during surgical procedures. JAMA 1991;265:1533-37.

  267. Short LJ, Bell DM. Risk of occupational infection with bloodborne pathogens in operating and delivery room settings.  Am J Infect Control 1993;21:343-50.

  268. Kristensen MS, Sloth E, Jensen TK. Relationship between anesthetic procedure and contact of anesthesia personnel with patient body fluids. Anesthesiology 1990;73:619-24.

  269. Beck-Sagué CM, Jarvis WR, Fruehling JA et al. Universal Precautions and mortuary practitioners: influence on practices and risk of occupationally acquired infection. J Occup Med 1991;33:874-78.

  270. Turner SB, Kunches LM, Gordon KF et al. Occupational exposure to human immunodeficiency virus (HIV) and hepatitis B  virus (HBV) among embalmers: a pilot seroprevalence study. Am J Public Health 1989;79:1425-26.

  271. McPherson DC, Parris NB. Reducing occupational exposure to blood in the OR. Today's O.R. Nurse, 1992;14:23-7.

  272. Fortner PA. Safety in intraoperative care.  Semin Perioper Nurs 1994;3:200-04.

  273. ADA. Infection Control recommendations for the dental office and the dental laboratory. J Am Dent Assoc 1992;123(suppl):1-8.

  274. Canadian Dental Association. CDA guidelines. Ottawa: Can Dental Assoc, 1992.

  275. Zabel P, Robichaud N, Hiltz A. Facilities and equipment for aseptic and safe handling of blood products. J Nucl Med Technol  1992;20:236-41. 2

  276. Health Canada. Infection control guidelines for long-term care facilities. Ottawa: Health Canada, 1994.  (Supply and Services Canada, Cat. No. H30-11-6-6-1994E.) 277. Long GE, Rickman LS. Infectious complications of tattoos.  Clin infectious diseases 1994;18:610-19.

 

[Previous] [Table of Contents] [Next]
Last Updated: 2002-11-08 Top
Important Notices